X-linked Lymphoproliferative Syndrome Type 2 (XLP-2)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which X-linked Lymphoproliferative Syndrome Type 2 (XLP-2) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 3

NCT06309823

A Single-patient Clinical Trial of MAS825 in a Patient With XIAP Deficiency

MAS825 is a bi-specific IgG1 monoclonal antibody that simultaneously targets IL-1 beta and IL-18, thereby neutralizing both cytokines that are thought to be int…

Canada1 participantsStarted 2023-02-08

Treatment: MAS825